{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:41:37Z","timestamp":1792190497235,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Binzhou Medical University Clinical X+ Project","award":["BY2021LCX12"],"award-info":[{"award-number":["BY2021LCX12"]}]},{"name":"Shandong Natural Science Fundation","award":["ZR2022MH141 and ZR2016HM19"],"award-info":[{"award-number":["ZR2022MH141 and ZR2016HM19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36706-9","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:04:11Z","timestamp":1768874651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cholangiocarcinoma derived exosomes attenuate the anti-tumor functions of NK cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Xinyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lebin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"36706_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","volume":"16","author":"PM Rodrigues","year":"2021","unstructured":"Rodrigues, P. M. et al. Pathogenesis of cholangiocarcinoma. Annu. Rev. Pathol. 16, 433\u2013463. https:\/\/doi.org\/10.1146\/annurev-pathol-030220-020455 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"36706_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley, P. J. et al. Cholangiocarcinoma. Nat. Rev. Dis. Primers. 7, 65. https:\/\/doi.org\/10.1038\/s41572-021-00300-2 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"36706_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris, D. et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J. Clin. 73, 198\u2013222. https:\/\/doi.org\/10.3322\/caac.21759 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"36706_CR4","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","volume":"10","author":"I Terr\u00e9n","year":"2019","unstructured":"Terr\u00e9n, I., Orrantia, A., Vitall\u00e9, J., Zenarruzabeitia, O. & Borrego, F. NK cell metabolism and tumor microenvironment. Front. Immunol. 10, 2278. https:\/\/doi.org\/10.3389\/fimmu.2019.02278 (2019).","journal-title":"Front. Immunol."},{"key":"36706_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-030-49270-0_4","volume":"1273","author":"C Guillerey","year":"2020","unstructured":"Guillerey, C. NK cells in the tumor microenvironment. Adv. Exp. Med. Biol. 1273, 69\u201390. https:\/\/doi.org\/10.1007\/978-3-030-49270-0_4 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"36706_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/jlb.Mr0718-269r","volume":"105","author":"I Prager","year":"2019","unstructured":"Prager, I. & Watzl, C. Mechanisms of natural killer cell-mediated cellular cytotoxicity. J. Leukoc. Biol. 105, 1319\u20131329. https:\/\/doi.org\/10.1002\/jlb.Mr0718-269r (2019).","journal-title":"J. Leukoc. Biol."},{"key":"36706_CR7","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1158\/1078-0432.Ccr-15-0685","volume":"21","author":"L Mart\u00ednez-Lostao","year":"2015","unstructured":"Mart\u00ednez-Lostao, L., Anel, A. & Pardo, J. How do cytotoxic lymphocytes kill cancer cells? Clin. Cancer Res. 21, 5047\u20135056. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-0685 (2015).","journal-title":"Clin. Cancer Res."},{"key":"36706_CR8","doi-asserted-by":"publisher","unstructured":"Meza Guzman, L. G., Keating, N. & Nicholson, S. E. Natural Killer Cells: Tumor Surveillance and Signaling. Cancers 12, 952 (2020). https:\/\/doi.org\/10.3390\/cancers12040952","DOI":"10.3390\/cancers12040952"},{"key":"36706_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.5mir0917-351r","author":"HF Aqbi","year":"2018","unstructured":"Aqbi, H. F., Wallace, M., Sappal, S., Payne, K. K. & Manjili, M. H. IFN-\u03b3 orchestrates tumor elimination, tumor dormancy, tumor escape, and progression. J. Leukoc. Biol. https:\/\/doi.org\/10.1002\/jlb.5mir0917-351r (2018).","journal-title":"J. Leukoc. Biol."},{"key":"36706_CR10","doi-asserted-by":"publisher","first-page":"1190333","DOI":"10.3389\/fimmu.2023.1190333","volume":"14","author":"J Han","year":"2023","unstructured":"Han, J., Wu, M. & Liu, Z. Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy. Front. Immunol. 14, 1190333. https:\/\/doi.org\/10.3389\/fimmu.2023.1190333 (2023).","journal-title":"Front. Immunol."},{"key":"36706_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molimm.2017.12.002","volume":"110","author":"SE Nicholson","year":"2019","unstructured":"Nicholson, S. E., Keating, N. & Belz, G. T. Natural killer cells and anti-tumor immunity. Mol. Immunol. 110, 40\u201347. https:\/\/doi.org\/10.1016\/j.molimm.2017.12.002 (2019).","journal-title":"Mol. Immunol."},{"key":"36706_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.15252\/embr.201439363","volume":"16","author":"JS Schorey","year":"2015","unstructured":"Schorey, J. S., Cheng, Y., Singh, P. P. & Smith, V. L. Exosomes and other extracellular vesicles in host-pathogen interactions. EMBO Rep. 16, 24\u201343. https:\/\/doi.org\/10.15252\/embr.201439363 (2015).","journal-title":"EMBO Rep."},{"key":"36706_CR13","doi-asserted-by":"publisher","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367 https:\/\/doi.org\/10.1126\/science.aau6977 (2020).","DOI":"10.1126\/science.aau6977"},{"key":"36706_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen, D. K. et al. Reassessment of exosome composition. Cell 177, 428\u2013445. https:\/\/doi.org\/10.1016\/j.cell.2019.02.029 (2019).","journal-title":"Cell"},{"key":"36706_CR15","doi-asserted-by":"publisher","unstructured":"Doyle, L. M. & Wang, M. Z. Overview of extracellular Vesicles, their Origin, Composition, Purpose, and methods for exosome isolation and analysis. Cells 8 https:\/\/doi.org\/10.3390\/cells8070727 (2019).","DOI":"10.3390\/cells8070727"},{"key":"36706_CR16","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. The biology, function, and applications of exosomes in cancer. Acta Pharm. Sin B. 11, 2783\u20132797. https:\/\/doi.org\/10.1016\/j.apsb.2021.01.001 (2021).","journal-title":"Acta Pharm. Sin B"},{"key":"36706_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-021-01376-w","volume":"20","author":"R Hosseini","year":"2021","unstructured":"Hosseini, R. et al. The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells. Mol. Cancer. 20, 83. https:\/\/doi.org\/10.1186\/s12943-021-01376-w (2021).","journal-title":"Mol. Cancer"},{"key":"36706_CR18","doi-asserted-by":"publisher","unstructured":"Zhou, Y., Zhang, Y., Gong, H., Luo, S. & Cui, Y. The role of exosomes and their applications in cancer. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms222212204 (2021).","DOI":"10.3390\/ijms222212204"},{"key":"36706_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cells8060558","volume":"8","author":"Q Han","year":"2019","unstructured":"Han, Q., Zhao, H., Jiang, Y., Yin, C. & Zhang, J. HCC-Derived exosomes: critical player and target for cancer immune escape. Cells 8, 558. https:\/\/doi.org\/10.3390\/cells8060558 (2019).","journal-title":"Cells"},{"key":"36706_CR20","doi-asserted-by":"publisher","first-page":"113009","DOI":"10.1016\/j.biopha.2022.113009","volume":"150","author":"AH Amin","year":"2022","unstructured":"Amin, A. H. et al. Role of acute myeloid leukemia (AML)-Derived exosomes in tumor progression and survival. Biomed. Pharmacother. 150, 113009. https:\/\/doi.org\/10.1016\/j.biopha.2022.113009 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"36706_CR21","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1007\/s13277-015-4313-2","volume":"37","author":"A Labani-Motlagh","year":"2016","unstructured":"Labani-Motlagh, A. et al. Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity. Tumour Biol. 37, 5455\u20135466. https:\/\/doi.org\/10.1007\/s13277-015-4313-2 (2016).","journal-title":"Tumour Biol."},{"key":"36706_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-019-1041-z","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Exosomal circrnas: biogenesis, effect and application in human diseases. Mol. Cancer. 18, 116. https:\/\/doi.org\/10.1186\/s12943-019-1041-z (2019).","journal-title":"Mol. Cancer"},{"key":"36706_CR23","doi-asserted-by":"publisher","unstructured":"Mashouri, L. et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol. Cancer. 18 https:\/\/doi.org\/10.1186\/s12943-019-0991-5 (2019).","DOI":"10.1186\/s12943-019-0991-5"},{"key":"36706_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.18632\/genesandcancer.172","volume":"9","author":"S Bae","year":"2018","unstructured":"Bae, S., Brumbaugh, J. & Bonavida, B. Exosomes derived from cancerous and non-cancerous cells regulate the anti-tumor response in the tumor microenvironment. Genes Cancer. 9, 87\u2013100. https:\/\/doi.org\/10.18632\/genesandcancer.172 (2018).","journal-title":"Genes Cancer"},{"key":"36706_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0295-2","volume":"51","author":"DH Kim","year":"2019","unstructured":"Kim, D. H. et al. Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer. Exp. Mol. Med. 51, 1\u201313. https:\/\/doi.org\/10.1038\/s12276-019-0295-2 (2019).","journal-title":"Exp. Mol. Med."},{"key":"36706_CR26","doi-asserted-by":"publisher","first-page":"15177","DOI":"10.3390\/ijms232315177","volume":"23","author":"T Huyan","year":"2022","unstructured":"Huyan, T. et al. miR-221-5p and miR-186-5p are the critical bladder cancer derived Exosomal MiRNAs in natural killer cell dysfunction. Int. J. Mol. Sci. 23, 15177. https:\/\/doi.org\/10.3390\/ijms232315177 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"36706_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02221-2","volume":"21","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Exosomal LncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC. Cancer Cell Int. 21, 1\u201316. https:\/\/doi.org\/10.1186\/s12935-021-02221-2 (2021).","journal-title":"Cancer Cell Int."},{"key":"36706_CR28","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3892\/ijmm.2020.4736","volume":"46","author":"X Zhu","year":"2020","unstructured":"Zhu, X. et al. Oral cancer cell\u2013derived exosomes modulate natural killer cell activity by regulating the receptors on these cells. Int. J. Mol. Med. 46, 2115\u20132125. https:\/\/doi.org\/10.3892\/ijmm.2020.4736 (2020).","journal-title":"Int. J. Mol. Med."},{"key":"36706_CR29","doi-asserted-by":"publisher","first-page":"14684","DOI":"10.1038\/s41598-017-14661-w","volume":"7","author":"CS Hong","year":"2017","unstructured":"Hong, C. S. et al. Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia. Sci. Rep. 7, 14684. https:\/\/doi.org\/10.1038\/s41598-017-14661-w (2017).","journal-title":"Sci. Rep."},{"key":"36706_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40199-020-00372-7","volume":"28","author":"M Moloudizargari","year":"2020","unstructured":"Moloudizargari, M., Redegeld, F., Asghari, M. H., Mosaffa, N. & Mortaz, E. Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity. Daru 28, 647\u2013659. https:\/\/doi.org\/10.1007\/s40199-020-00372-7 (2020).","journal-title":"Daru"},{"key":"36706_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13205-021-02817-5","volume":"11","author":"H Yu","year":"2021","unstructured":"Yu, H. et al. Acute lymphoblastic leukemia-derived exosome inhibits cytotoxicity of natural killer cells by TGF-\u03b2 signaling pathway. 3 Biotech. 11, 313. https:\/\/doi.org\/10.1007\/s13205-021-02817-5 (2021).","journal-title":"3 Biotech."},{"key":"36706_CR32","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","volume":"185","author":"R Pan","year":"2022","unstructured":"Pan, R., Ryan, J., Pan, D., Wucherpfennig, K. W. & Letai, A. Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis. Cell 185, 1521\u20131538e1518. https:\/\/doi.org\/10.1016\/j.cell.2022.03.030 (2022).","journal-title":"Cell"},{"key":"36706_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.15171\/apb.2019.024","volume":"9","author":"R Jan","year":"2019","unstructured":"Jan, R. & Chaudhry, G. E. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv. Pharm. Bull. 9, 205\u2013218. https:\/\/doi.org\/10.15171\/apb.2019.024 (2019).","journal-title":"Adv. Pharm. Bull."},{"key":"36706_CR34","doi-asserted-by":"publisher","first-page":"119317","DOI":"10.1016\/j.bbamcr.2022.119317","volume":"1869","author":"P Wolf","year":"2022","unstructured":"Wolf, P., Schoeniger, A. & Edlich, F. Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane. Biochim. Biophys. Acta Mol. Cell. Res. 1869, 119317. https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119317 (2022).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"36706_CR35","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1182\/blood-2018-02-791350","volume":"132","author":"R Valentin","year":"2018","unstructured":"Valentin, R., Grabow, S. & Davids, M. S. The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood 132, 1248\u20131264. https:\/\/doi.org\/10.1182\/blood-2018-02-791350 (2018).","journal-title":"Blood"},{"key":"36706_CR36","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/icb.2017.72","volume":"95","author":"EM Carrington","year":"2017","unstructured":"Carrington, E. M. et al. The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules. Immunol. Cell. Biol. 95, 870\u2013877. https:\/\/doi.org\/10.1038\/icb.2017.72 (2017).","journal-title":"Immunol. Cell. Biol."},{"key":"36706_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000348747","volume":"91","author":"L Yang","year":"2013","unstructured":"Yang, L., Wu, X., Wang, D., Luo, C. & Chen, L. Renal carcinoma cell-derived exosomes induce human immortalized line of Jurkat T lymphocyte apoptosis in vitro. Urol. Int. 91, 363\u2013369. https:\/\/doi.org\/10.1159\/000348747 (2013).","journal-title":"Urol. Int."},{"key":"36706_CR38","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbrc.2019.04.051","volume":"513","author":"JN Deng","year":"2019","unstructured":"Deng, J. N. et al. Exosomes derived from plasma of septic patients inhibit apoptosis of T lymphocytes by down-regulating bad via hsa-miR-7-5p. Biochem. Biophys. Res. Commun. 513, 958\u2013966. https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.051 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"36706_CR39","doi-asserted-by":"publisher","unstructured":"Zhao, J. et al. Tumor-Derived extracellular vesicles inhibit natural killer cell function in pancreatic cancer. Cancers 11 https:\/\/doi.org\/10.3390\/cancers11060874 (2019).","DOI":"10.3390\/cancers11060874"},{"key":"36706_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","volume":"19","author":"PF Zhang","year":"2020","unstructured":"Zhang, P. F. et al. Cancer cell-derived Exosomal circUHRF1 induces natural killer cell exhaustion and May cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol. Cancer. 19, 110. https:\/\/doi.org\/10.1186\/s12943-020-01222-5 (2020).","journal-title":"Mol. Cancer"},{"key":"36706_CR41","doi-asserted-by":"publisher","first-page":"21474","DOI":"10.1016\/S0021-9258(20)80561-4","volume":"268","author":"R Li","year":"1993","unstructured":"Li, R. et al. A leukocyte integrin binding peptide from intercellular adhesion molecule-2 stimulates T cell adhesion and natural killer cell activity. J. Biol. Chem. 268, 21474\u201321477 (1993).","journal-title":"J. Biol. Chem."},{"key":"36706_CR42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1083\/jcb.129.4.1143","volume":"129","author":"R Li","year":"1995","unstructured":"Li, R. et al. A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b\/CD18 and CD11c\/CD18. J. Cell. Biol. 129, 1143\u20131153. https:\/\/doi.org\/10.1083\/jcb.129.4.1143 (1995).","journal-title":"J. Cell. Biol."},{"key":"36706_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-642-46859-9_7","volume":"230","author":"TS Helander","year":"1998","unstructured":"Helander, T. S. & Timonen, T. Adhesion in NK cell function. Curr. Top. Microbiol. Immunol. 230, 89\u201399. https:\/\/doi.org\/10.1007\/978-3-642-46859-9_7 (1998).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"36706_CR44","doi-asserted-by":"publisher","first-page":"21280","DOI":"10.1074\/jbc.M807053200","volume":"284","author":"X Zheng","year":"2009","unstructured":"Zheng, X., Wang, Y., Wei, H., Sun, R. & Tian, Z. LFA-1 and CD2 synergize for the Erk1\/2 activation in the natural killer (NK) cell immunological synapse. J. Biol. Chem. 284, 21280\u201321287. https:\/\/doi.org\/10.1074\/jbc.M807053200 (2009).","journal-title":"J. Biol. Chem."},{"key":"36706_CR45","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.4049\/jimmunol.145.10.3194","volume":"145","author":"MJ Robertson","year":"1990","unstructured":"Robertson, M. J., Caligiuri, M. A., Manley, T. J., Levine, H. & Ritz, J. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J. Immunol. 145, 3194\u20133201 (1990).","journal-title":"J. Immunol."},{"key":"36706_CR46","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/eji.201646492","volume":"46","author":"A R\u00f6lle","year":"2016","unstructured":"R\u00f6lle, A. et al. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur. J. Immunol. 46, 2420\u20132425. https:\/\/doi.org\/10.1002\/eji.201646492 (2016).","journal-title":"Eur. J. Immunol."},{"key":"36706_CR47","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/hep.510240629","volume":"24","author":"D Luo","year":"1996","unstructured":"Luo, D. et al. The role of adhesion molecules in the recruitment of hepatic natural killer cells (pit cells) in rat liver. Hepatology 24, 1475\u20131480. https:\/\/doi.org\/10.1002\/hep.510240629 (1996).","journal-title":"Hepatology"},{"key":"36706_CR48","doi-asserted-by":"publisher","unstructured":"Orange, J. S. et al. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc. Natl. Acad. Sci. U. S. A. 100, 14151\u201314156 (2003). https:\/\/doi.org\/10.1073\/pnas.1835830100","DOI":"10.1073\/pnas.1835830100"},{"key":"36706_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1006\/cimm.1994.1208","volume":"157","author":"AS Chong","year":"1994","unstructured":"Chong, A. S., Boussy, I. A., Jiang, X. L., Lamas, M. & Graf, L. H. Jr. CD54\/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell. Immunol. 157, 92\u2013105. https:\/\/doi.org\/10.1006\/cimm.1994.1208 (1994).","journal-title":"Cell. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36706-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:20:23Z","timestamp":1770801623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36706-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36706"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36706-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"19 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods are reported in accordance with the Declaration of Helsinki. The studies involving human participants were reviewed and approved by the Ethics Committees of Binzhou Medical University Hospital (KYLL-2022-46). The patients\/participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"5810"}}